![]() The Logistics Business segment operates ports and transfer station terminals, as well as upriver transport facilities in the Hidrovia region and handles vessels, barges, push boats, and cabotage business. This segment charters its vessels to trading houses, producers, and government-owned entities. The Dry Bulk Vessel Operations segment engages in the transportation and handling of bulk cargoes through the ownership, operation, and trading of vessels and freight. The company operates in two segments, Dry Bulk Vessel Operations and Logistics Business. It focuses on the transportation and transshipment of dry bulk commodities, including iron ores, coal, and grains. ![]() operates as a seaborne shipping and logistics company in North America, Australia, Europe, Asia, South America, and internationally. St Georges Eco-Mining Technologies (117).Small Cap Coronavirus COVID-19 Stocks (1).AGORACOM Small Cap Stocks For Investment (3).AGORACOM Client Intelligence Report (13).To learn more about the Palliative Program, visit October 7, 2021 “Psychedelic Palliative Care by Novamind is designed to address this need, bringing together fast-acting medicine, innovative treatment options and therapeutic expertise in a safe, nurturing environment.” “Our healthcare system struggles to support the millions of Americans dealing with emotional, spiritual and psychological suffering associated with chronic or serious illness,” noted Dr. Thielking leads the Palliative Program’s multidisciplinary team of mental health professionals specialized in palliative care and psychedelic-assisted psychotherapy. He also pioneered an ongoing HCI study examining the feasibility of group-administered psilocybin-assisted psychotherapy for cancer patients experiencing depression. Thielking developed ketamine-assisted treatment protocols for cancer patients experiencing depression at the University of Utah Huntsman Cancer Institute (HCI). This work will build on notable studies from New York University and Johns Hopkins University, which demonstrated psilocybin’s significant immediate and sustained improvements in anxiety and depression symptoms in cancer patients. Through Novamind’s clinical research division, the Palliative Program will host studies to investigate the use of psychedelic medicine including ketamine and establish the infrastructure for future clinical studies examining psilocybin. “Due to psychedelic medicine’s generally low side effect burden and fast-acting nature, it shows promise for patients who are physically ill and might have limited life expectancies.” ![]() Paul Thielking, Chief Scientific Officer (CSO) of Novamind. Unfortunately, standard anti-depression and anti-anxiety treatments do not work for everyone, can cause side effects, and can take up to eight weeks to work,” explained Dr. “Patients receiving palliative care have higher rates of depression than the general population. We are pleased to launch Psychedelic Palliative Care by Novamind (the “Palliative Program”) at its recently opened clinic and research site in Murray, Utah.Īmong the first-of-its-kind, the Palliative Program combines psychedelic medicine with psychotherapy, workshops, multi-day immersive retreats and group support for palliative care patients and families who are coping with chronic and serious illness. ![]() Novamind Launches New Psychedelic Palliative Care Program
0 Comments
Leave a Reply. |